Skip to main content

Peer Review reports

From: Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report

Original Submission
2 Jul 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 Oct 2016 Editorially accepted
18 Oct 2016 Article published 10.1186/s12883-016-0720-2

You can find further information about peer review here.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us